Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 62
Filter
1.
Int J Obstet Anesth ; 57: 103939, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37891124

ABSTRACT

BACKGROUND: Little information exists regarding attitudes related to the presence of the partner in the operation room (OR) during category 1 emergency cesarean section (cat. 1 CS). We investigated how cat. 1 CS under general anesthesia is experienced, both by partners present in the OR and those not. METHODS: An explorative prospective cohort trial, with qualitative elements, involving all cat. 1 CS in 2022 in two hospitals. At site 1 the partner was present in the OR during cat. 1 CS, whereas at site 2 the partner was not. Parents and staff answered questionnaires following each cat. 1 CS and semi-structured interviews with partners were held three months after surgery. Qualitative data were analyzed using content analysis. The primary outcome was the partner's answer to the question: "Would you have preferred not being present/being present in the OR?" respectively. RESULTS: Seventeen and eight cat. 1 CS occurred at each site respectively. All parents agreed to participate. No partners in site 1 would have preferred to wait outside, and all evaluated the experience very positively. Partners at site 2 also evaluated not being present positively. Overarching themes from the qualitative analysis were "Being the family witness" and "Experience of being the partner". Mothers and staff from site 1 were very positive about their partners' presence. CONCLUSION: Partners present in the OR during cat. 1 CS under general anesthesia evaluated this very positively. Most partners, who had not been present in the OR, also evaluated this positively. No partners had post-traumatic stress.


Subject(s)
Cesarean Section , Operating Rooms , Female , Humans , Pregnancy , Mothers , Prospective Studies
2.
Sustain Sci ; 16(2): 703-708, 2021.
Article in English | MEDLINE | ID: mdl-33686348

ABSTRACT

Enduring sustainability challenges requires a new model of collective leadership that embraces critical reflection, inclusivity and care. Leadership collectives can support a move in academia from metrics to merits, from a focus on career to care, and enact a shift from disciplinary to inter- and trans-disciplinary research. Academic organisations need to reorient their training programs, work ethics and reward systems to encourage collective excellence and to allow space for future leaders to develop and enact a radically re-imagined vision of how to lead as a collective with care for people and the planet. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11625-021-00909-y.

3.
Anaesthesia ; 76(2): 261-269, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32506615

ABSTRACT

It is difficult to pool results from randomised clinical trials that report different outcomes. We want to develop a core set of pain-related outcomes after total hip or knee arthroplasty, the first stage of which is to systematically review published outcomes. We searched PubMed, Embase and CENTRAL for relevant trials to January 2020. We identified 165 outcomes from 565 trials with 50,668 participants, which we categorised into six domains: pain; analgesic consumption; quality of care; adverse events; mobility; and patient-reported outcome measures. The outcome in each domain reported by most trials was: visual analogue score for pain, 401 (71%); morphine consumption, 212 (38%); length of hospital stay, 166 (29%); nausea or vomiting, 425 (75%); range of motion, 173 (31%); and patient satisfaction score, 181 (32%). A primary outcome was reported in 281 (50%) trials: 101 (18%) trials reported consumption of rescue analgesics and 95 (17%) trials reported pain. We plan to publish a consensus on outcomes that should be reported in postoperative pain trials after hip or knee arthroplasty.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Pain, Postoperative/drug therapy , Pain, Postoperative/epidemiology , Analgesics/therapeutic use , Analgesics, Opioid/therapeutic use , Humans , Morphine , Randomized Controlled Trials as Topic
4.
Scand J Surg ; 107(2): 99-106, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29277136

ABSTRACT

BACKGROUND AND AIMS: Endoscopic retrograde cholangiopancreatography followed by laparoscopic cholecystectomy is often used as definitive treatment for common bile duct stones. The aim of this study was to investigate the optimal time interval between endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy. MATERIALS AND METHODS: PubMed and Embase were searched for studies comparing different time delays between endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy. Observational studies and randomized controlled trials were included. Primary outcome was conversion rate from laparoscopic to open cholecystectomy and secondary outcomes were complications, mortality, operating time, and length of stay. RESULTS: A total of 14 studies with a total of 1930 patients were included. The pooled estimate revealed an increase from a 4.2% conversion rate when laparoscopic cholecystectomy was performed within 24 h of endoscopic retrograde cholangiopancreatography to 7.6% for 24-72 h delay to 12.3% when performed within 2 weeks, to 12.3% for 2-6 weeks, and to a 14% conversion rate when operation was delayed more than 6 weeks. CONCLUSION: According to this systematic review, it is preferable to perform cholecystectomy within 24 h of endoscopic retrograde cholangiopancreatography to reduce conversion rate. Early laparoscopic cholecystectomy does not increase mortality, perioperative complications, or length of stay and on the contrary it reduces the risk of reoccurrence and progression of disease in the delay between endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy.


Subject(s)
Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy, Laparoscopic , Conversion to Open Surgery , Gallstones/surgery , Postoperative Complications/epidemiology , Humans , Time Factors
5.
J Vet Pharmacol Ther ; 34(3): 277-84, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20950347

ABSTRACT

Sulfadiazine (SDZ) and trimethoprim (TMP) concentrations were examined in plasma and pulmonary epithelial lining fluid (PELF), following intravenous and oral administration and compared to minimum inhibitory concentrations (MICs) of common bacterial isolates from equine lower airway infections. SDZ/TMP (25/5 mg/kg) was administered intravenously, intragastric or per os to fed horses, and blood samples were collected before and 11 times, over 24 h, after administration. PELF samples were collected via a tampon device four times after drug administration and analysed for drug concentrations. Additionally, MICs of SDZ and TMP alone and in combination were determined in a selection of clinical respiratory isolates. Bioavailability was 74% for SDZ and 46% for TMP after paste administration in fed horses. The degree of penetration of SDZ and TMP into PELF, as described by AUC(PELF) /AUC(plasma) ratios, was 0.68 and 0.72, respectively, after intravenous administration. After oral administration, the degree of penetration for SDZ and TMP was 0.92 and 0.46, respectively. MIC measurements using SDZ/TMP ratios of 5:1 and 10:1 did not affect the interpretation of the results. The results indicate that clinically relevant drug concentrations of mainly TMP are difficult to maintain in PELF, especially after oral administration of SDZ/TMP.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Horses/metabolism , Respiratory Mucosa/metabolism , Sulfadiazine/pharmacokinetics , Trimethoprim/pharmacokinetics , Administration, Oral , Animals , Anti-Bacterial Agents/administration & dosage , Biological Availability , Chromatography, High Pressure Liquid/veterinary , Drug Administration Schedule/veterinary , Escherichia coli/drug effects , Female , Injections, Intravenous/veterinary , Microbial Sensitivity Tests/veterinary , Staphylococcus aureus/drug effects , Streptococcus equi/drug effects , Sulfadiazine/administration & dosage , Trimethoprim/administration & dosage
6.
J Vet Pharmacol Ther ; 34(3): 285-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20950348

ABSTRACT

Doxycycline concentrations, following two types of oral administration to horses, in pulmonary epithelial lining fluid (PELF) were examined and compared to plasma concentrations. The oral bioavailability was estimated from plasma concentrations achieved after an intravenous study in two horses. Doxycycline (10 mg/kg) was administered either intragastric or as topdressing to nonfasted horses. Blood samples were collected for drug analysis, before and 11 times after administration during 24 h. PELF samples were collected by a tampon device four times after drug administration and analysed for doxycycline concentrations. Another two horses received doxycycline intravenously at a dose of 3 mg/kg and plasma was taken 14 times during a 24- h period. The oral bioavailability of doxycycline was calculated to 17% after intragastric administration and 6% after topdressing administration in nonfasted horses. The degree of penetration of doxycycline into PELF, as described by AUC(PELF) /AUC(plasma) ratios, was 0.87 after intragastric administration. The results indicate that clinically relevant doxycycline concentrations are possible to maintain in PELF after intragastric administration. Furthermore, if bioavailability could be enhanced for per os administration, doxycycline might be a valuable drug for the treatment of lower airway infections in horses.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Bronchoalveolar Lavage Fluid/chemistry , Doxycycline/pharmacokinetics , Respiratory Mucosa/metabolism , Administration, Oral , Animals , Anti-Bacterial Agents/administration & dosage , Biological Availability , Chromatography, High Pressure Liquid/veterinary , Doxycycline/administration & dosage , Drug Administration Schedule/veterinary , Escherichia coli/drug effects , Female , Horses , Injections, Intravenous/veterinary , Mass Spectrometry/veterinary , Microbial Sensitivity Tests/veterinary , Pasteurella/drug effects , Staphylococcus aureus/drug effects , Streptococcus equi/drug effects
7.
J Vet Pharmacol Ther ; 34(5): 482-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21083664

ABSTRACT

Cefquinome concentrations, following intravenous and aerosol administration to horses, in pulmonary epithelial lining fluid (PELF) were examined and compared to plasma concentrations. Single dose of cefquinome sulphate (1 mg/kg) was administered intravenously to six horses followed by a single aerosol administration (225 mg) with a wash-out period of 14 days between treatments. After each drug administration, cefquinome concentrations in plasma and PELF, obtained by intrabronchial cotton swabs, were determined. After intravenous administration, cefquinome concentrations in plasma declined fast and were not detectable after 12 h. After aerosol administration, plasma concentrations were low or below limit of quantification (LOQ) during the entire sampling period. The degree of penetration of cefquinome into PELF after intravenous administration as described by the AUC(PELF) /AUC(plasma) ratio was 0.33. Following aerosol administration, cefquinome concentrations in PELF were high, but only detectable for 4 h. Based on AUC values, total cefquinome concentrations in PELF were one-third of total plasma concentrations after intravenous administration together with shorter time above Minimum Inhibitory Concentrations (T > MIC) in PELF, thus twice daily dosing may be required when treating lower airway infections in horses. Lower doses of cefquinome can be administered as aerosols providing high local drug concentrations in lung, but additional optimization of formulation is needed to improve distribution and persistence in lung.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Cephalosporins/pharmacokinetics , Horses/metabolism , Lung/metabolism , Respiratory Mucosa/metabolism , Animals , Anti-Bacterial Agents/metabolism , Area Under Curve , Body Fluids/chemistry , Cephalosporins/metabolism , Half-Life , Tissue Distribution
8.
J Dev Orig Health Dis ; 1(5): 310-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-25141934

ABSTRACT

The biological mechanisms in the association between maternal body mass index (BMI) and birth weight are not well understood, but are likely to involve maternal plasma glucose levels and nutrient transport across the placenta, both important modulators of fetal growth. Adipose tissue contributes to circulating levels of interleukins that may affect glucose metabolism and possibly also placental transport of nutrients. We investigated possible mediating roles of Interleukin 6 (IL-6) and Interleukin 1 Receptor antagonist (IL-1Ra) in 208 pregnant women. Known and hypothesized dependencies between BMI in early pregnancy and fasting glucose, IL-1Ra and IL-6 at gestational weeks 30-32, and birth weight were specified in a path diagram. Standardized regression coefficients, expressing direct, indirect and total effects, were estimated by Bayesian path analysis. Mean (s.d.) BMI was 24.9 kg/m2 (4.2) and mean (s.d.) birth weight 3748 g (454). The total effect of BMI on birth weight was 0.24 (95% credibility interval (CrI) [0.12, 0.36]). The direct effect of IL-1Ra on birth weight was not statistically significant, but significant effects of BMI on IL-1Ra (0.61, 95% CrI [0.51, 0.72]), of IL-1Ra on fasting glucose (0.17, 95% CrI [0.01, 0.34]) and of fasting glucose on birth weight (0.14, 95% CrI [0.01, 0.27]) implied an indirect pathway from BMI via IL-1Ra on birth weight. Approximately 20% of the effect of BMI on birth weight was mediated through IL-1Ra. For IL-6, no such effects were found. Our results indicate that IL-1Ra may be a mediator in the association between BMI and birth weight.

9.
Drugs R D ; 7(1): 33-42, 2006.
Article in English | MEDLINE | ID: mdl-16620135

ABSTRACT

BACKGROUND: Exogenous insulin does not prevent cardiac failure in patients with type 1 diabetes mellitus and a cardioprotective insulin mimic is greatly needed. Certain transition metals are known to act as insulin mimics and may be cardio- protective. In this study, the ability of a newly synthesised molybdenum/ascorbic acid complex to strengthen cardiac function was investigated. METHODS AND DESIGN: Male CD rats were assigned to one of five groups: non-diabetic control, non-diabetic control treated with molybdenum/ascorbic acid complex, diabetic treated with sodium ascorbate, diabetic treated with molybdenum/ascorbic acid complex and untreated diabetics. Type 1 diabetes was induced by streptozocin injection. Once diabetes was confirmed, treatment was initiated by adding either the molybdenum/ascorbic acid complex or sodium ascorbate to the drinking water and continued for 6 weeks. Following the treatment period, the animals were terminated, and their hearts were excised and mounted in a working heart perfusion apparatus. Blood samples were taken for plasma glucose and plasma lipid level determination. Cardiac function was evaluated using 1 hour of low-flow ischaemic stress followed by 30 minutes of reperfusion. RESULTS: Hearts from the animals treated with the molybdenum/ascorbic acid complex displayed the best aerobic performance of all the diabetic animals. Blood glucose levels and blood lipid levels were significantly lower in animals treated with the complex than in other diabetic animals. The group treated with the complex also had a lower drinking rate than the other diabetic groups. Furthermore, hearts from animals treated with the molybdenum/ascorbic acid complex showed a greater degree of recovery from low-flow ischaemia than any other group. CONCLUSIONS: The molybdenum/ascorbic acid complex showed some significant insulin-mimic and cardioprotective effects. Further development of this complex could provide a drug useful for alleviating some of the cardiovascular problems associated with diabetes mellitus.


Subject(s)
Ascorbic Acid/therapeutic use , Cardiomyopathies/prevention & control , Diabetes Mellitus, Experimental/drug therapy , Molybdenum/therapeutic use , Animals , Blood Glucose/analysis , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/physiopathology , Heart/drug effects , Heart/physiology , Insulin , Lipids/blood , Male , Myocardial Ischemia/physiopathology , Rats , Rats, Inbred Strains , Streptozocin
10.
Res Vet Sci ; 79(1): 61-7, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15894026

ABSTRACT

The theory of a time-dependent effect of amoxycillin was examined in a model of porcine Actinobacillus pleuropneumoniae (Ap)-infection using clinically relevant dosage regimens. Twenty hours after infection of fourteen pigs, when clinical signs of pneumonia were present, one group of pigs received a single dose of amoxycillin (20 mg/kg, i.m.), whereas another group received four doses of 5 mg/kg injected at 8-h intervals. A similar AUC of the plasma amoxycillin concentration versus time curve was obtained in the two groups, whereas the maximum concentration was threefold higher using the single high dose. Plasma amoxycillin was above the MIC for twice as long using the fractionated dosage scheme. The condition of the animals was evaluated by clinical and haematological observations combined with quantification of biochemical infection markers: C-reactive protein, zinc and ascorbic acid. Within 48 h of treatment, the pigs in both treatment groups recovered clinically. No significant differences in the time-course of clinical observations or plasma concentrations of the biomarkers of infection were observed between the two treatments. In conclusion, the efficacy of these two dosage regimens of amoxycillin was not significantly different in treatment of acute Ap-infection in pigs.


Subject(s)
Actinobacillus Infections/veterinary , Actinobacillus pleuropneumoniae , Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Swine Diseases/drug therapy , Actinobacillus Infections/drug therapy , Amoxicillin/pharmacokinetics , Animals , Anti-Bacterial Agents/pharmacokinetics , Area Under Curve , Drug Administration Schedule/veterinary , Male , Swine
12.
Res Vet Sci ; 74(3): 261-70, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12726745

ABSTRACT

Biomarkers of infection were screened for their possible role as evaluators of antibiotic treatment in an aerosol infection model of porcine pneumonia caused by Actinobacillus pleuropneumoniae (Ap). Following infection of 12 pigs, clinical signs of pneumonia developed within 20 h, whereafter the animals received a single dose of either danofloxacin (2.5mg/kg) or tiamulin (10 mg/kg). To test the discriminative properties of the biomarkers, the dosage regimens were designed with an expected difference in therapeutic efficacy in favour of danofloxacin. Accordingly, the danofloxacin-treated pigs recovered clinically within 24h after treatment, whereas tiamulin-treated animals remained clinically ill until the end of the study, 48 h after treatment. A similar picture was seen for the biomarkers of infection. During the infection period, plasma C-reactive protein (CRP), interleukin-6 and haptoglobin increased, whereas plasma zinc, ascorbic acid and alpha-tocopherol decreased. In the danofloxacin-treated animals, CRP, interleukin-6, zinc, ascorbic acid and alpha-tocopherol reverted significantly towards normalisation within 24h of treatment. In contrast, signs of normalisation were absent (CRP, zinc and ascorbic acid) or less marked (interleukin-6 and alpha-tocopherol) in the tiamulin-treated animals. Plasma haptoglobin remained elevated throughout the study in both groups. This indicates that CRP, zinc, ascorbic acid and to a lesser extent interleukin-6 and alpha-tocopherol might be used to evaluate antibiotic treatment of acute Ap-infection in pigs. The present model provides a valuable tool in the evaluation of antibiotic treatments, offering the advantage of clinical and pathological examinations combined with the use of biochemical infection markers.


Subject(s)
Actinobacillus Infections/veterinary , Actinobacillus pleuropneumoniae , Anti-Infective Agents/pharmacology , Diterpenes/pharmacology , Fluoroquinolones , Pleuropneumonia/veterinary , Swine Diseases/drug therapy , Swine Diseases/microbiology , Actinobacillus Infections/blood , Actinobacillus Infections/drug therapy , Actinobacillus Infections/microbiology , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Ascorbic Acid/blood , Biomarkers/blood , C-Reactive Protein/metabolism , Diterpenes/therapeutic use , Haptoglobins/metabolism , Interleukin-6/blood , Leukocyte Count/veterinary , Lung/pathology , Macrolides , Male , Pleuropneumonia/blood , Pleuropneumonia/drug therapy , Pleuropneumonia/microbiology , Random Allocation , Swine , Swine Diseases/blood , Zinc/blood , alpha-Tocopherol/blood
13.
J Vet Pharmacol Ther ; 25(5): 351-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12423225

ABSTRACT

Body condition has been shown to affect the pharmacokinetics of subcutaneously administered macrocyclic lactone anthelmintics but the underlying mechanism is unknown. This study examined the effect of different rates of fat deposition on the pharmacokinetics of moxidectin (MXD) and ivermectin (IVM). All animals initially received a diet with a high linoleic acid content for 7 weeks. One group of animals then received a normal grower diet while the other half received a maintenance ration. Within each diet group, animals were treated with either IVM (n = 4) or MXD (n = 4) or remained as untreated controls (n = 2). There was no difference in the proportion of linoleic acid between the drug treated groups and the untreated controls at any time throughout the study. At 4 and 9 weeks after treatment there was a significantly lower proportion of linoleic acid in the pigs fed the normal ration indicating a greater fat deposition in these animals compared with those that received the maintenance diet. There was an increased persistence of MXD in the plasma of pigs fed the normal ration compared with those fed the maintenance ration. No differences were seen in the kinetic disposition of IVM between pigs fed the maintenance or normal ration. Reducing the rate of fat deposition influenced the pharmacokinetic disposition of the highly lipophilic MXD but did not influence the pharmacokinetic disposition of the less lipophilic IVM.


Subject(s)
Adipose Tissue/metabolism , Anti-Bacterial Agents/pharmacokinetics , Ivermectin/pharmacokinetics , Linoleic Acid/metabolism , Swine/metabolism , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/blood , Area Under Curve , Chromatography, Liquid/veterinary , Diet , Female , Injections, Subcutaneous/veterinary , Ivermectin/administration & dosage , Ivermectin/blood , Macrolides , Male
14.
J Vet Pharmacol Ther ; 25(3): 227-32, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12081618

ABSTRACT

Macrocyclic lactones are characterized by their long persistence in animals because of their extensive distribution into fat. This study examined the influence of body condition on the disposition of ivermectin (IVM) and moxidectin (MXD) in blood and fat following subcutaneous (s.c.) drug administration. 'Fat' and 'thin' lines of pigs were established using two different diets. All animals were then injected with either MXD or IVM at 300 microg/kg and blood samples were taken at regular intervals until slaughter. Two IVM-treated animals from each diet group were slaughtered at either 3 days or 3 weeks posttreatment. Two MXD-treated animals from each diet group were slaughtered at 3 days, 3, 6 or 9 weeks after treatment. Samples of backfat were taken from all animals at slaughter. Fluorescence HPLC was used to determine the concentrations of MXD or IVM in the plasma and fat samples. The plasma IVM concentration peaked more rapidly in the thin IVM treated pigs compared with the fat pigs. The concentration of IVM in backfat was significantly lower in the thin animals slaughtered 3 weeks after treatment. The MXD plasma concentration peaked within the first hour in both the thin and fat groups, but from 12 h posttreatment there was a higher MXD concentration in the plasma of the fat pigs resulting in MXD being detectable in these pigs for 28 days compared with only 17 days in the thin pigs. Despite this difference in plasma persistence no differences were seen in the MXD concentration of backfat between fat and thin animals. Body condition influenced the kinetic disposition of IVM and MXD following s.c. drug administration with both drugs being less persistent in thin compared with fat animals.


Subject(s)
Anthelmintics/pharmacokinetics , Anti-Bacterial Agents/pharmacokinetics , Body Composition , Ivermectin/pharmacokinetics , Swine/metabolism , Adipose Tissue/metabolism , Animals , Anthelmintics/administration & dosage , Anti-Bacterial Agents/administration & dosage , Area Under Curve , Chromatography, High Pressure Liquid , Female , Injections, Subcutaneous/veterinary , Ivermectin/administration & dosage , Macrolides , Male
15.
J Vet Pharmacol Ther ; 24(2): 99-104, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11442783

ABSTRACT

Macrocyclic lactones (ML) are highly effective anthelmintics that provide a long protective period after administration because of their extensive distribution into fat. This study examined whether the body composition of the animal at the time of treatment had any influence on the pharmacokinetics of two MLs, moxidectin (MOX) and ivermectin (IVM). 'Fat' and 'lean' lines of pigs were established using two different diets, with weekly determination of liveweight and backfat thickness confirming the difference in body condition between the groups. Blood samples were taken at regular intervals following i.v. injection of IVM or MOX at a dose of 300 microg/kg and the plasma was analysed using fluorescence high performance liquid chromatography (HPLC) to determine the concentration of IVM or MOX in the samples. Regardless of body composition IVM and MOX kinetics were very different with MOX having a greater apparent volume of distribution, longer distribution and elimination half-lives and a slower clearance rate than IVM, which led to MOX being detectable in plasma for >40 days compared with only 8-10 days for IVM. Altering body composition had no detectable influence on the kinetic disposition of IVM in this study. In contrast, although there was no difference in AUC or the volume of distribution, MOX was distributed within and eliminated from the lean animals more rapidly than from the fat animals.


Subject(s)
Anthelmintics/pharmacokinetics , Anti-Bacterial Agents/pharmacokinetics , Ivermectin/pharmacokinetics , Animals , Anthelmintics/administration & dosage , Anti-Bacterial Agents/administration & dosage , Body Composition , Female , Injections, Intravenous , Ivermectin/administration & dosage , Kinetics , Macrolides , Male , Swine
16.
Vet Hum Toxicol ; 43(3): 147-51, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11383654

ABSTRACT

Senecio vernalis and other plants containing pyrrolizidine alkaloids (PA) are implicated in the poisoning of cattle. The liver is a known target organ. In this study the content of the alkaloids senecionine (SCO), senkirkin (SKK) and seneciphyllin (SCP) and their toxic effects in cattle were studied. The content of these 3 compounds only varied by a factor of 2 within 10 plant collections at different locations in western Denmark (Jutland). However, individual alkaloids varied 3-fold, and the interplant variation for some of the PA up to 8-fold. SCO and SKK had very short half lives, 20 min and 70 min respectively. In cattle fed dried plant material corresponding to 200 and 400 g of fresh material for 10 d alanine aminotransferase, alkaline phosphatase and g-glutamyl transferase activities remained unchanged. Cattle subsequently fed fresh plant material up to 1 kg/d for 8 d also had no change in liver enzyme activities. Cattle did not show any clinical signs of poisoning, and no morphological liver changes were observed.


Subject(s)
Animal Feed/analysis , Cattle Diseases/chemically induced , Plant Poisoning/veterinary , Plants, Toxic/chemistry , Pyrrolizidine Alkaloids/analysis , Pyrrolizidine Alkaloids/toxicity , Senecio , Animals , Cattle , Cattle Diseases/metabolism , Chromatography, High Pressure Liquid/veterinary , Denmark , Female , Liver/drug effects , Liver/enzymology , Liver/pathology , Plant Poisoning/metabolism , Plant Poisoning/pathology , Pyrrolizidine Alkaloids/isolation & purification , Pyrrolizidine Alkaloids/pharmacokinetics , gamma-Glutamyltransferase/metabolism
17.
Biochimie ; 83(2): 201-12, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11278070

ABSTRACT

We have analysed the complete sequence of the Escherichia coli K12 isolate MG1655 genome for chromatin-associated protein binding sites, and compared the predicted location of predicted sites with experimental expression data from 'DNA chip' experiments. Of the dozen proteins associated with chromatin in E. coli, only three have been shown to have significant binding preferences: integration host factor (IHF) has the strongest binding site preference, and FIS sites show a weak consensus, and there is no clear consensus site for binding of the H-NS protein. Using hidden Markov models (HMMs), we predict the location of 608 IHF sites, scattered throughout the genome. A subset of the IHF sites associated with repeats tends to be clustered around the origin of replication. We estimate there could be roughly 6000 FIS sites in E. coli, and the sites tend to be localised in two regions flanking the replication termini. We also show that the regions upstream of genes regulated by H-NS are more curved and have a higher AT content than regions upstream of other genes. These regions in general would also be localised near the replication terminus.


Subject(s)
Bacterial Proteins/genetics , Chromatin/genetics , DNA, Bacterial/genetics , DNA-Binding Proteins/genetics , Escherichia coli Proteins , Escherichia coli/genetics , Genome, Bacterial , Binding Sites , Carrier Proteins/metabolism , DNA Replication , Factor For Inversion Stimulation Protein , Integration Host Factors , Oligonucleotide Array Sequence Analysis/methods , Operon , Plasmids , Repetitive Sequences, Nucleic Acid
18.
Pharmacol Toxicol ; 87(4): 174-8, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11097271

ABSTRACT

The P450 enzymes of the liver are responsible for the metabolism of a wide range of chemical compounds, and hepatocytes are used in pharmacological and toxicological in vitro tests. Thus, it is important to know how stable these enzymes are in culture. We measured the activity of CYP2A and CYP3A in microsomes isolated from both pig liver and primary pig hepatocyte cultures, together with the apoprotein concentration using Western blotting. The CYP2A activity and apoprotein concentration decreased rapidly; only about 5 percent remained after 48 hr incubation, whereas the CYP3A activity and apoprotein concentration was constant. CYP3A was induced 3 times after exposure to rifampicin, whereas neither rifampicin nor pyrazole could induce CYP2A. The hepatocytes were also incubated with varying concentration of FCS and autologous serum, however without effect on the stability of CYP2A, nor did different concentrations of growth hormone and testosterone added to the cultures have any effect.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Cytochrome P-450 Enzyme Inhibitors , Enzyme Inhibitors/pharmacology , Hepatocytes/drug effects , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Oxidoreductases, N-Demethylating/antagonists & inhibitors , Steroid Hydroxylases/antagonists & inhibitors , Animals , Apoproteins/metabolism , Cells, Cultured , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System/metabolism , Female , Hepatocytes/enzymology , Hepatocytes/metabolism , Microsomes, Liver/metabolism , Oxidoreductases, N-Demethylating/metabolism , Pyrazoles/pharmacology , Rifampin/pharmacology , Steroid Hydroxylases/metabolism , Swine
19.
Am J Vet Res ; 61(8): 992-6, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10951996

ABSTRACT

OBJECTIVE: To determine pharmacokinetics and tissue distribution of amoxicillin in healthy and Salmonella Typhimurium-inoculated pigs. ANIMALS: 12 healthy pigs and 12 S Typhimurium-inoculated pigs. PROCEDURE: Concentration of amoxicillin in tissue was measured by use of high-performance liquid chromatography 4, 8, 12, and 24 hours after IM administration. Pharmacokinetic values of amoxicillin in plasma were assessed by use of a 1-compartment model with first-order absorption. RESULTS: Inoculation caused diarrhea and increased rectal temperature and WBC count. Absorption half-life was shorter in inoculated pigs (0.26 hours) than in healthy pigs (0.71 hours), and inoculated pigs had longer elimination half-life. Distribution ratios in healthy pigs ranged from 0.31 to 0.56 and in inoculated pigs ranged from 0.14 to 0.48. Ratios for distribution to intestinal mucosa ranged from 0.34 to 1.16 in healthy pigs and from 0.22 to 0.36 in inoculated pigs. CONCLUSIONS AND CLINICAL RELEVANCE: Salmonella Typhimurium inoculation altered absorption of amoxicillin from the injection site and prolonged elimination half-life. However, distribution of amoxicillin to intestinal tract tissue was only affected to a minor degree.


Subject(s)
Amoxicillin/pharmacokinetics , Penicillins/pharmacokinetics , Salmonella Infections, Animal/drug therapy , Salmonella typhimurium/drug effects , Swine Diseases/drug therapy , Amoxicillin/blood , Animals , Area Under Curve , Body Temperature , Cecum/microbiology , Chromatography, High Pressure Liquid/veterinary , Colon/microbiology , Colony Count, Microbial , Diarrhea/veterinary , Female , Gastrointestinal Contents/microbiology , Half-Life , Jejunum/microbiology , Leukocyte Count/veterinary , Penicillins/blood , Random Allocation , Salmonella Infections, Animal/blood , Salmonella Infections, Animal/microbiology , Statistics, Nonparametric , Swine , Swine Diseases/microbiology
20.
Res Vet Sci ; 68(3): 211-6, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10877965

ABSTRACT

The pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy pigs and in pigs experimentally infected with Salmonella typhimurium were studied. In the infected pigs, a decrease in body clearance and an increase in mean elimination half-life was observed (P < 0.01). Moreover a significant reduction in the volume of the peripheral compartment was found. Danofloxacin distributed well to the gastrointestinal tract achieving high AUC / AUC(plasma)ratios in both groups of pigs. However, compared to the healthy pigs AUC / AUC(plasma)ratios decreased in the infected pigs. Salmonella infection led to an increase in mean residence time (MRT) in the small intestines and lymph nodes and a decrease in MRT in caecum and colon.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Digestive System/metabolism , Fluoroquinolones , Salmonella Infections, Animal/metabolism , Salmonella typhimurium , Swine Diseases/metabolism , Swine/metabolism , Animals , Intestinal Mucosa/metabolism , Male , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...